A 52-year old man was referred to our service for evaluation after being diagnosed with oropharyngeal squamous cell carcinoma. Contrast-enhanced computed tomography (CT) revealed a mass in the left tonsillar pillar, as well as submental lymphadenopathy. The extent of tumor infiltration was assessed by fluoro-2-deoxyglucose positron emission tomography scans, which showed increased uptake in the tumor bed and a suspicious-looking lymph node near the right hilum. No other signs or symptoms of distant metastasis were evident at that time, and the patient was treated with induction chemotherapy followed by chemoradiation. Several weeks after treatment completion, the patient returned, complaining of right medial foot edema. CT of the right lower extremity revealed multiple high-attenuation masses in the soft tissues of the right leg and foot, including a mass in the medial plantar region of the foot. Approximately 15 to 20% of patients with oropharyngeal squamous cell carcinoma develop distant metastasis throughout the course of the disease. Soft-tissue metastases from oropharyngeal cancers are rare, however, particularly when they present in the absence of widespread metastasis. A review of the current head and neck tumor literature describes soft-tissue metastases in less than 10% of patients with known distant metastases. Metastasis to distal regions such as the lower extremities has rarely been observed but should be included in the differential diagnosis for patients presenting with lower-extremity pain or edema.
Introduction
Oropharyngeal cancer is relatively uncommon. Worldwide, cancers of the oropharynx and hypopharynx account for an estimated 123,000 new cases per year, with an estimated mortality of 79,000 deaths. 1 In the United States, the 2004 incidence was estimated to be 28,260 new cases per year with a mortality of 7,230, accounting for more than 20% of worldwide cases. 2 Histologically, almost all oropharyngeal cancers are squamous cell carcinomas (SCCs). 3 Other malignant neoplasms in this area include minor salivary gland carcinomas, lymphomas, and lymphoepitheliomas. SCCs may be noninvasive or invasive, and they display a wide variety of differentiation, with most defined as moderately or poorly differentiated. 4 The most common site for metastasis from oropharyngeal cancer is the cervical lymph nodes, with variability among the different levels of nodal metastasis based on where the primary tumor lies. Distant metastases are relatively uncommon as a first site of failure as compared to local invasion and regional recurrence. When present, distant spread occurs most commonly to the lungs, followed by bone, liver, and mediastinal sites. 5 It generally occurs in patients who present with advanced disease, especially in those with pathologically proven lymph nodes at multiple levels of the neck or in the lower neck. Alternate sites of distant metastases are rare, and few cases are described in current literature.
This article describes a case of oropharyngeal SCC with unusual metastatic presentation to the foot and lower extremity shortly after diagnosis and treatment of the primary neoplasm. This diagnosis was obtained after thorough clinical, imaginologic, histopathologic, and immunohistochemical evaluation.
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Case report
A 52-year old man was referred to our service for evaluation after being diagnosed with oropharyngeal SCC. He initially had presented with leftsided throat pain and odynophagia of several weeks' duration that was refractory to an antibiotic trial. Then, during an intraoral examination, a palpable mass was verified in the region of the left tonsillar pillar; it had a smooth surface and firm consistency. Extraoral examination revealed tenderness to palpation of the left side of the neck, but no palpable lymphadenopathy. Computed tomography (CT) of the neck revealed a soft-tissue mass measuring 2.1 × 2.0 cm within the left tonsillar pillar, obstructing the vallecula, and submental lymphadenopathy measuring 1.4 × 9 mm. In view of these findings, the patient underwent panendoscpopy and biopsy, revealing moderately differentiated invasive SCC of the left pharyngeal tonsil and postcricoid larynx that was suspicious for lymphovascular invasion.
Positron emission tomography (PET)/CT was performed, which showed a mass in the oropharynx measuring 5.5 × 4.2 × 11 cm with a standardized uptake value of 13, an enlarged tonsillar fossa, and a suspicious lymph node in the right hilum. The patient's cancer was deemed inoperable, and he was initially treated with induction chemotherapy consisting of cisplatin, 5-fluorouracil, and docetaxel.
External beam radiation therapy was then initiated, utilizing 3-D conformal modality. It was delivered to a total dose of 6,600 cGy divided in 33 fractions using 6 MV photons and 9 MeV electrons. All fields were treated to a dose of 4,400 cGy, with a 2,200 cGy boost to the tumor bed. Treatment regions included the right and left lateral neck fields, bilateral supraclavicular lymph node regions, and left neck tumor and lymph node mass (encompassing bilateral cervical lymph node levels II to V), with a boost to the tonsillar region. Custom blocks were used to protect the spinal cord and mandible.
Radiation therapy was accomplished over 6.5 weeks and was tolerated well except for some mild dysphagia and mild odynophagia throughout treatment. The patient received cetuximab concomitantly with his radiation therapy; all treatment was concluded within 6 months of the initial diagnosis.
Several weeks after treatment completion, the patient returned with complaints of right medial foot edema, chest pain, and shortness of breath. He was evaluated with deep venous ultrasound, CT angiography of the chest, right foot x-ray, and CT of the right lower extremity. These studies ultimately revealed multiple high-attenuation masses in the soft tissues of the right leg and foot, including masses in the vastus lateralis and rectus femoris muscles, the perivascular fat of the popliteal fossa, the posteromedial gastrocnemius and flexor hallicus longus muscles, and the medial plantar region of the foot.
One of the right thigh masses was amenable to biopsy, which was performed. It revealed pathologic metastatic disease consistent with the primary diagnosis of oropharyngeal SCC ( figure) .
The patient received palliative treatment for the unusual metastatic foci in the right lower extremity. The right thigh was treated with 15 MeV electrons to 40.5 Gy/18 fractions and a 0.5-cm bolus to the 90% isodose line. The right foot was treated with 3-D conformal radiation therapy using 6 MV photon energy to a dose of 40.5 Gy/18 fractions and with a 0.5-cm bolus to the 98% isodose line. The right calf was treated with 6 MV 3-D conformal radiotherapy to a total dose of 40.5 Gy/18 fractions to the 99% isodose line. This was accomplished over a period of 4 weeks. The patient ultimately went on to develop distant metastasis at other sites and was treated palliatively. He was later placed on hospice and died approximately 9 months after the diagnosis of oropharyngeal SCC.
Discussion
SCC of the tonsil is the second most common malignancy of the head and neck and the most common location for a primary tumor of the oropharynx. 6 However, it is rarely associated with distant soft-tissue metastasis at, or soon after, presentation. 7 Patients generally present initially with symptoms from the primary tonsillar lesion that may include dysphagia, odynophagia, weight loss, ipsilateral referred otalgia, and a mass in the neck. In later stages, patients present with symptoms specific to the location of their metastases.
The most common site for metastasis from oropharyngeal cancer is the cervical lymph nodes, with variability among the different levels of nodal metastasis based on the position of the primary tumor. The overall incidence of cervical lymph node involvement from cancer of the oropharynx is approximately 70%. 8 Bilateral cervical lymph node metastases are common, as well-up to 50%. 8 Posterior pharyngeal wall cancers drain bilaterally to jugular chain nodes (levels II, III, and IV) and the retropharyngeal nodes of Ranvier. Cancers of the tonsillar region drain primarily to the upper and mid jugular chain nodes and to the submandibular nodes (levels I, II, and III). Posterior triangle nodes (level V) are usually last to become involved. Lymphatic drainage for carcinoma of the anterior tonsil and tonsillar pillar is generally to level II lymph nodes, while lesions of the tonsillar fossa/ posterior pillar generally drain to level V nodes. 6 Distant metastasis, or metastatic disease outside the cervical lymph nodes, can be a significant problem in patients with carcinoma of the oropharynx, occurring in approximately 15 to 20% of all patients over the course of the disease. 9 It is, however, a relatively uncommon first site of failure as compared to local invasion and regional recurrence, and it occurs most commonly in lung, bone, liver, and mediastinum. Metastasis from oropharyngeal carcinoma has also been observed to involve the central nervous system in 1 to 2% of patients throughout the course of the disease. 10 Other sites of metastasis from various SCCs of the head and neck have rarely been described.
A review of the current head and neck tumor literature describes the aforementioned distribution of distant metastasis, with each study citing the lung as the most common site of distant metastasis. [11] [12] [13] Other, less common, sites of metastasis from various head and neck SCCs include skin, brain, adrenal gland, heart, kidney, peritoneum, soft tissue, spleen, and prostate.
A review of 546 patients with oropharyngeal SCCs by Merino et al yielded distant metastasis in the following locations: lung in 52% of patients, bone in 20.3%, liver in 6%, mediastinum in 2.9%, lung and bone in 3.3%, and others in 15.4%. 11 Another review of 89 patients with metastatic oropharyngeal SCC by Kowalski et al revealed metastasis in the following locations: lung in 58.4% of patients, bone in 37.1%, liver in 3.4%, brain in 3.4%, and soft tissue in 2.2%. 12 Finally, a review of 39 patients with various head and neck SCCs by Alvarez Marcos et al yielded distant metastasis in lung in 58% of patients, bone in 22%, liver in 9%, soft tissue in 9%, and others in 2%. 13 Based on our review, there are cases to date of softtissue metastasis from head and neck SCCs, but they have not been specifically identified as primary oropharyngeal SCC. There have been occasional reports of soft-tissue and intramuscular metastasis from oropharyngeal SCC, but our review did not discover any cases with metastasis as far-reaching as the foot and lower extremity in the absence of other widespread metastasis.
One case published several years ago describes softtissue metastasis to the right upper arm, 14 but it was limited to a single site in the biceps muscle. Distant metastasis in the gluteal musculature of a 65-year-old woman with SCC of the larynx has been described, 15 and soft-tissue metastasis to the arms and upper thighs of a 66-year-old woman with oropharyngeal SCC was recently described, but it occurred concomitantly with widespread metastasis. 16 In our case, the pattern of advanced hematogenous spreading of metastases is unique. The metastases were located solely in the soft tissues of a lower extremity, particularly in the skeletal musculature. PET/CT revealed a questionable mediastinal node, but CT of the chest showed no evidence of cardiac or liver metastases, and signs and symptoms of central nervous system or other metastatic lesions were negative. Thus, in the presence of masses of unknown origin in the lower extremities in patients who had or currently have SCC of the oropharynx, metastases should be taken into consideration. We OrOpharyngeal squamOus cell carcinOma metastatic tO lOwer-extremity sOft tissues: a case repOrt and literature review suggest that a thorough examination for such findings be performed on these patients during routine oncologic follow-up.
